Access
This article is part of Nature's premium content.
Please note this is News in Brief, and so will be a short article.
Published online 6 August 2008 | Nature 454, 679 (2008) | doi:10.1038/454679a
News in Brief
Stanford psychiatrist removed from drug study
To read this story in full you will need to login or make a payment (see right).
Please note this is News in Brief, and so will be a short article.
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email redesign@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.
Unfortunately, this is probably only the tip of the iceberg. The alliance between psychiatry and drug companies is profitable and widespread in this country. The losers are the patients and Medicare.